Printer Friendly

Sigma-Aldrich settles with Enzo and Yale.

St. Louis, MO 9/19/06; Farmingdale, NY 9/19/06--Sigma-Aldrich announced that it has settled with Enzo Biochem, Enzo Life Sciences and Yale University. The 2002 patent infringement law suit charged Sigma-Aldrich, Amersham Biosciences, PerkinElmer Life Sciences, Molecular Probes and Orchid Biosciences, as well as associated subsidiaries, with breach of contract, patent infringement and unfair competition, among other charges related to Enzo Biochem's labeled nucleotide products and technology, according to Enzo (see IBO 10/31/02). Enzo Biochem stated, "Enzo is pleased to have settled with Sigma-Aldrich on favorable terms. Sigma is the first defendant to settle in the various actions brought by Enzo. Additional defendants in the various actions include Affymetrix Inc., Roche Diagnostics, Amersham Biosciences, Inc., Perkin Elmer, Inc., Orchid Biosciences, Inc. and Molecular Probes, Inc. We continue to aggressively pursue our claims with respect to the remaining defendants."

Under the agreement, Sigma-Aldrich will pay Enzo $2 million. The settlement will no doubt put pressure on the other defendants to also settle. The only defendant from which Enzo Biochem recorded revenues in fiscal year 2005 was PerkinElmer.
COPYRIGHT 2006 Strategic Directions International Inc. (SDI)
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Executive Briefing: News, Trends & Market Intelligence for Instrument Executives
Publication:Instrument Business Outlook
Date:Sep 30, 2006
Previous Article:Applied Biosystems and Promega settle legal disputes.
Next Article:Private equity firm invests in lab supplier.

Related Articles
Enzo Biochem files suit against eight Life Science companies. (Executive Briefing).
The bottom line.
Stratagene and Takara settle PCR suits.
Sigma-Aldrich files suit for infringement of RNAi patents.
Sigma-Aldrich and Oxford BioMedica pursue protection of RNAi-related intellectual property; file suit against Open Biosystems.
Sigma-Aldrich adds to service offerings.
The bottom line.
Sigma-Aldrich buys chiral chromatography firm.
Court dismisses claims in Enzo Biotech v. Applied Biosystems.
Sigma-Aldrich and Oxford BioMedica win key ruling in open biosystems patent Infringement dispute.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |